Standards for the development and methodology of the 2023 IWGDF guidelines.

Sicco A Bus Matilde Monteiro Soares Frances Game Jaap J Van NettenJan ApelqvistRobert Fitridge Eric M SennevilleNicolaas C Schapernull null

Published in: Diabetes/metabolism research and reviews (2023)

We believe that the adoption and implementation of the 2023 IWGDF guidelines by healthcare providers, public health agencies, and policymakers will improve the prevention and management of diabetes-related foot disease, and subsequently reduce the worldwide patient and societal burden caused by this disease.

Keyphrases

healthcare
public health
type diabetes
clinical practice
primary care
case report
skeletal muscle
insulin resistance
drug induced
weight loss
affordable care act